The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging.

With increasing effectiveness of antiretroviral therapy, people with HIV (PWH) are living longer and the prevalence of older PWH continues to increase. Accordingly, PWH are experiencing an increased burden of age-related comorbidities. With this shifting demographic, clinicians and researchers face additional challenges in how to identify, address, and manage the complex intersections of HIV- and aging-related conditions. Established in 2009, the International Workshop on HIV and Aging brings together clinicians and researchers in cross-disciplinary fields along with community advocates and PWH to address the multidisciplinary nature of HIV and aging. This article summarizes plenary talks from the 10th Annual International Workshop on HIV and Aging, which took place in New York City on October 10 and 11, 2019. Presentation topics included: the burdens of HIV-associated comorbidities, aging phenotypes, community engagement, and loneliness; these issues that are especially important for older PWH considering the current COVID-19 pandemic. We also discuss broad questions and potential directions for future research necessary to better understand the interaction between HIV and aging.

[1]  B. Meisner,et al.  Interdisciplinary and Collaborative Approaches Needed to Determine Impact of COVID-19 on Older Adults and Aging: CAG/ACG and CJA/RCV Joint Statement , 2020, Canadian Journal on Aging / La Revue canadienne du vieillissement.

[2]  S. Letendre,et al.  Frailty and HIV disease severity synergistically increase risk of HIV-associated Neurocognitive Disorders. , 2020, Journal of acquired immune deficiency syndromes.

[3]  K. Bandeen-Roche,et al.  Frailty transitions, inflammation and mortality among persons aging with HIV infection and injection drug use. , 2020, AIDS.

[4]  Richard D Moore,et al.  Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada , 2020, Journal of the International AIDS Society.

[5]  P. Reiss,et al.  Frailty Is Associated With Mortality and Incident Comorbidity Among Middle-Aged Human Immunodeficiency Virus (HIV)–Positive and HIV-Negative Participants , 2020, The Journal of infectious diseases.

[6]  I. Grant,et al.  Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV. , 2020, Journal of acquired immune deficiency syndromes.

[7]  Jessica L. Montoya,et al.  Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging. , 2019, AIDS research and human retroviruses.

[8]  Samah J. Jarad,et al.  Polypharmacy, hazardous alcohol and illicit substance use and serious falls among PLWH and uninfected comparators. , 2019, Journal of acquired immune deficiency syndromes.

[9]  Richard D Moore,et al.  Life-Expectancy Disparities Among Adults With HIV in the United States and Canada: The Impact of a Reduction in Drug- and Alcohol-Related Deaths Using the Lives Saved Simulation Model , 2019, American journal of epidemiology.

[10]  Richard D Moore,et al.  LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care , 2019, Open Forum Infectious Diseases.

[11]  M. Karris,et al.  HIV and Aging: Reconsidering the Approach to Management of Comorbidities. , 2019, Infectious disease clinics of North America.

[12]  A. Vos,et al.  Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. , 2019, The New England journal of medicine.

[13]  Bei Wu,et al.  Substance Use Among Older People Living With HIV: Challenges for Health Care Providers , 2019, Front. Public Health.

[14]  Jessica L. Montoya,et al.  Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates , 2019, Journal of the International Neuropsychological Society.

[15]  I. Wilson,et al.  Trends in Comorbid Conditions Among Medicaid Enrollees With HIV , 2019, Open forum infectious diseases.

[16]  R. Redfield,et al.  Ending the HIV Epidemic: A Plan for the United States. , 2019, JAMA.

[17]  K. Anastos,et al.  Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis. , 2019, AIDS patient care and STDs.

[18]  D. Martinusen,et al.  A Review of Cannabis in Chronic Kidney Disease Symptom Management , 2019, Canadian journal of kidney health and disease.

[19]  Richard D Moore,et al.  Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. , 2019, The lancet. HIV.

[20]  H. Uno,et al.  Effect of Marijuana Smoking on Pulmonary Disease in HIV-Infected and Uninfected Men: A Longitudinal Cohort Study , 2019, EClinicalMedicine.

[21]  V. Veloso,et al.  Trends and predictors of non‐communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil , 2019, Journal of the International AIDS Society.

[22]  C. Depp,et al.  High prevalence and adverse health effects of loneliness in community-dwelling adults across the lifespan: role of wisdom as a protective factor , 2018, International Psychogeriatrics.

[23]  E. Groce The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research , 2018, Journal of Medical Regulation.

[24]  P. Ghys,et al.  Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000–2020 , 2018, PloS one.

[25]  A. Winston,et al.  Patterns of Co-occurring Comorbidities in People Living With HIV , 2018, Open forum infectious diseases.

[26]  S. Kent,et al.  Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial. , 2018, The lancet. HIV.

[27]  K. Brummel-Ziedins,et al.  In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus , 2018, Research and practice in thrombosis and haemostasis.

[28]  Brandon D. L. Marshall,et al.  Changes in alcohol use associated with changes in HIV disease severity over time: A national longitudinal study in the Veterans Aging Cohort. , 2018, Drug and alcohol dependence.

[29]  M. Beibel,et al.  TORC1 inhibition enhances immune function and reduces infections in the elderly , 2018, Science Translational Medicine.

[30]  S. Rajagopalan,et al.  Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis , 2018, Circulation.

[31]  P. Rosenberg,et al.  Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030 , 2018, Annals of Internal Medicine.

[32]  A. Kahn,et al.  Cancer Risk in Older Persons Living With Human Immunodeficiency Virus Infection in the United States , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  J. Nachega,et al.  Prevalence and risk factors of metabolic syndrome in HIV‐infected adults at three urban clinics in a post‐conflict setting, eastern Democratic Republic of the Congo , 2018, Tropical medicine & international health : TM & IH.

[34]  N. Hessol,et al.  Loneliness in Older Adults Living with HIV , 2018, AIDS and Behavior.

[35]  Richard D Moore,et al.  Association of Increased Chronicity of Depression With HIV Appointment Attendance, Treatment Failure, and Mortality Among HIV-Infected Adults in the United States , 2018, JAMA psychiatry.

[36]  I. Bellantuono Find drugs that delay many diseases of old age , 2018, Nature.

[37]  H. Masur,et al.  Sexually Transmitted Infections Among HIV-Infected Individuals in the District of Columbia and Estimated HIV Transmission Risk: Data From the DC Cohort , 2018, Open forum infectious diseases.

[38]  Quincy M. Samus,et al.  Dementia prevention, intervention, and care , 2017, The Lancet.

[39]  Sally S Bebawy,et al.  Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor–Based Regimens , 2017, Journal of acquired immune deficiency syndromes.

[40]  J. Bigna,et al.  Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis. , 2017, The Lancet. Global health.

[41]  J. Capeau,et al.  Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. , 2017, AIDS.

[42]  J. Sterne,et al.  Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies , 2017, The lancet. HIV.

[43]  R. Kohanski,et al.  Geroscience and the trans-NIH Geroscience Interest Group, GSIG , 2017, GeroScience.

[44]  E. Wing HIV and aging. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[45]  F. Sierra Moving Geroscience Into Uncharted Waters. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[46]  J. Mefford,et al.  Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans , 2016, AIDS.

[47]  J. Lundgren,et al.  Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy , 2016, PloS one.

[48]  M. Lederman,et al.  CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  P. Reiss,et al.  HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls , 2016, AIDS.

[50]  Eileen M. Crimmins,et al.  Loneliness, eudaimonia, and the human conserved transcriptional response to adversity , 2015, Psychoneuroendocrinology.

[51]  L. Ferrucci,et al.  Accelerated Longitudinal Gait Speed Decline in HIV-Infected Older Men , 2015, Journal of acquired immune deficiency syndromes.

[52]  R. Varadhan,et al.  Frailty in Older Adults: A Nationally Representative Profile in the United States. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[53]  T. Hallett,et al.  Future challenges for clinical care of an ageing population infected with HIV: a modelling study , 2015, The Lancet. Infectious diseases.

[54]  Timothy B. Smith,et al.  Loneliness and Social Isolation as Risk Factors for Mortality , 2015, Perspectives on psychological science : a journal of the Association for Psychological Science.

[55]  Martin L. Miller,et al.  Friends Not Foes: CTLA-4 Blockade and mTOR Inhibition Cooperate during CD8+ T Cell Priming To Promote Memory Formation and Metabolic Readiness , 2015, The Journal of Immunology.

[56]  E. Schadt,et al.  Geroscience: Linking Aging to Chronic Disease , 2014, Cell.

[57]  M. Freiberg,et al.  Cardiovascular disease risk in an aging HIV population: not just a question of biology. , 2014, Current opinion in HIV and AIDS.

[58]  N. Mackman,et al.  Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. , 2014, Blood.

[59]  Maureen A. McGargill,et al.  mTOR modulates the antibody response to provide cross-protective immunity to lethal influenza infections , 2013, Nature Immunology.

[60]  M. Yin,et al.  Incident fractures in HIV-infected individuals: a systematic review and meta-analysis , 2013, AIDS.

[61]  L. Kuller,et al.  HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation , 2013, Journal of the American Heart Association.

[62]  W. Malarkey,et al.  Loneliness Promotes Inflammation During Acute Stress , 2013, Psychological science.

[63]  B. Wilsey,et al.  Low-dose vaporized cannabis significantly improves neuropathic pain. , 2013, The journal of pain : official journal of the American Pain Society.

[64]  G. Meintjes,et al.  HIV-Associated Tuberculosis 2012 , 2012, Clinical & developmental immunology.

[65]  L. Kuller,et al.  Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals , 2012, PloS one.

[66]  R. Baltussen,et al.  Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing , 2011, AIDS.

[67]  L. Hawkley,et al.  Loneliness Matters: A Theoretical and Empirical Review of Consequences and Mechanisms , 2010, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[68]  Timothy B. Smith,et al.  Social Relationships and Mortality Risk: A Meta-analytic Review , 2010, PLoS medicine.

[69]  D. Jacobs,et al.  Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. , 2010, The Journal of infectious diseases.

[70]  M. Lederman,et al.  Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. , 2010, Blood.

[71]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[72]  Lewis H Kuller,et al.  Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.

[73]  C. Sedikides,et al.  Counteracting Loneliness , 2008, Psychological science.

[74]  T. Schacker The role of secondary lymphatic tissue in immune deficiency of HIV infection , 2008, AIDS.

[75]  M. Hollenberg,et al.  Role of protease‐activated receptors in inflammatory responses, innate and adaptive immunity , 2008, Journal of leukocyte biology.

[76]  R. Varadhan,et al.  Higher levels and blunted diurnal variation of cortisol in frail older women. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[77]  I. Abramson,et al.  Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy Volunteers , 2007, Anesthesiology.

[78]  L. Hawkley,et al.  Social regulation of gene expression in human leukocytes , 2007, Genome Biology.

[79]  M. Rowbotham,et al.  Cannabis in painful HIV-associated sensory neuropathy , 2007, Neurology.

[80]  M. Lederman,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Nature Medicine.

[81]  Charles A Emlet,et al.  An examination of the social networks and social isolation in older and younger adults living with HIV/AIDS. , 2006, Health & social work.

[82]  L. Ferrucci,et al.  Phenotype of frailty: characterization in the women's health and aging studies. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[83]  S. Karpiak,et al.  The aging HIV/AIDS population: Fragile social networks , 2005, Aging & mental health.

[84]  D. Sane,et al.  Aging and Thrombosis , 2002, Seminars in thrombosis and hemostasis.

[85]  L. Fried,et al.  Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. , 2002, Archives of internal medicine.

[86]  L. Hawkley,et al.  Loneliness and Health: Potential Mechanisms , 2002, Psychosomatic medicine.

[87]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[88]  Ronald Glaser,et al.  Stress, loneliness, and changes in herpesvirus latency , 1985, Journal of Behavioral Medicine.

[89]  C E Speicher,et al.  Urinary Cortisol Levels, Cellular Immunocompetency, and Loneliness in Psychiatric Inpatients , 1984, Psychosomatic medicine.

[90]  J. Holt-Lunstad,et al.  Loneliness and Social Isolation as Risk Factors for Mortality: A Loneliness and Social Isolation as Risk Factors for Mortality: A Meta-Analytic Review Meta-Analytic Review , 2021 .

[91]  M. Siedner Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework , 2019, Journal of aging and health.

[92]  T. Schacker,et al.  Factor X Inhibition Reduces Coagulation Activity But Not Inflammation Among Persons Living with HIV: A Randomized Clinical Trial , 2019, Social Science Research Network.

[93]  R. Varadhan,et al.  Relationship of Physical Frailty to Phosphocreatine Recovery in Muscle After Mild Exercise Stress in the Oldest-Old Women , 2019, The Journal of Frailty & Aging.

[94]  Insight Esprit and Smart Study Groups Inflammation-Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It? , 2018 .

[95]  J. Brooks,et al.  Frailty and Pre-Frailty in a Contemporary Cohort of HIV-Infected Adults. , 2014, The Journal of frailty & aging.